+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Richter Gedeon Nyrt. - logo

Richter Gedeon is a Hungarian multinational pharmaceutical and biotechnology company headquartered in Budapest, Hungary. It is one of the largest companies of the industry in the Central and Eastern European region and has operations in over 40 countries. The company sells products for gynecology, the central nervous system, and cardiology areas among other therapeutic areas. The company was established in Budapest by Gedeon Richter, a pharmacist, in 1901.

Emergency Contraceptive Pills Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Thumbnail Image

Emergency Contraceptive Pills Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • March 2025
  • 181 Pages
  • Global
From
Osteoporosis Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Osteoporosis Therapeutics - Global Strategic Business Report

  • Report
  • May 2025
  • 340 Pages
  • Global
From
Teriparatide- Biosimilar Insight, 2022 - Product Thumbnail Image

Teriparatide- Biosimilar Insight, 2022

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Endometriosis Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2020-2030 - Product Thumbnail Image

Endometriosis Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2020-2030

  • Drug Pipelines
  • December 2022
  • 127 Pages
  • Global
From
Contraceptive Drugs - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Thumbnail Image

Contraceptive Drugs - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Drug Pipelines
  • July 2024
  • 150 Pages
  • Global
From
Biosimilar Growth Hormones Market Report 2025 - Product Thumbnail Image

Biosimilar Growth Hormones Market Report 2025

  • Report
  • April 2025
  • 250 Pages
  • Global
From
Emergency Contraceptive Pills Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) - Product Thumbnail Image

Emergency Contraceptive Pills Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • Report
  • January 2024
  • 170 Pages
  • Global
Endometriosis - Global Drug Forecast and Market Analysis to 2030 - Product Thumbnail Image

Endometriosis - Global Drug Forecast and Market Analysis to 2030

  • Report
  • December 2021
  • 124 Pages
  • Global
From
Rituximab Biosimilars Market Report and Forecast 2023-2031 - Product Thumbnail Image

Rituximab Biosimilars Market Report and Forecast 2023-2031

  • Report
  • April 2023
  • 147 Pages
  • Global
From
Trastuzumab-Biosimilars Insight, 2022 - Product Thumbnail Image

Trastuzumab-Biosimilars Insight, 2022

  • Report
  • January 2022
  • 125 Pages
  • Global
From
Global Biosimilars Business and Investment Opportunities - Analysis & Market Size by Technology, Clinical Trials, Patents, Financial Deals, Competitive Landscape - Q2 2023 Update - Product Thumbnail Image

Global Biosimilars Business and Investment Opportunities - Analysis & Market Size by Technology, Clinical Trials, Patents, Financial Deals, Competitive Landscape - Q2 2023 Update

  • Report
  • August 2023
  • 1300 Pages
  • Global
From
Osteoporosis Treatment Market Report 2025 - Product Thumbnail Image

Osteoporosis Treatment Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Osteoporosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Osteoporosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • August 2022
  • 375 Pages
  • Global
From
Post Menopausal Osteoporosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Post Menopausal Osteoporosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • August 2022
  • 149 Pages
  • Global
From
Desogestrel Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Thumbnail Image

Desogestrel Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • February 2024
  • 90 Pages
  • Global
From
Drospirenone API Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Thumbnail Image

Drospirenone API Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • February 2024
  • 85 Pages
  • Global
From
Levonorgestrel Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Thumbnail Image

Levonorgestrel Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • February 2024
  • 87 Pages
  • Global
From
Pharma and ESG: The Patient Perspective, 2023 - The Views of 832 Patient Groups from Around the World - Product Thumbnail Image

Pharma and ESG: The Patient Perspective, 2023 - The Views of 832 Patient Groups from Around the World

  • Report
  • November 2023
  • 63 Pages
  • Global
Rheumatoid Arthritis (Immunology) - Drugs in Development, 2021 - Product Thumbnail Image

Rheumatoid Arthritis (Immunology) - Drugs in Development, 2021

  • Drug Pipelines
  • March 2021
  • Global
From
Rituximab-Biosimilars Insight, 2022 - Product Thumbnail Image

Rituximab-Biosimilars Insight, 2022

  • Report
  • January 2022
  • 125 Pages
  • Global
From
Loading Indicator